tiprankstipranks
Trending News
More News >
XTL Biopharmaceuticals Ltd. (IL:XTLB)
:XTLB
Israel Market
Advertisement

Xtl Bio (XTLB) Income Statement

Compare
1 Followers

Xtl Bio Income Statement

Last quarter (Q1 2024), Xtl Bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Xtl Bio's net income was $485.00K. See Xtl Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 451.00K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 3.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 2.17M$ 765.00K$ 880.00K$ 1.03M$ 948.00K
Depreciation and Amortization
$ 199.00K$ 1.00K$ 1.00K$ 1.00K$ 1.00K
EBITDA
$ -930.00K$ -764.00K$ -879.00K$ -1.03M$ -947.00K
Operating Income
$ -2.17M$ -765.00K$ -880.00K$ -1.03M$ -948.00K
Other Income/Expenses
$ 1.01M$ -1.02M$ -468.00K$ 1.47M$ -2.01M
Pretax Income
$ -1.16M$ -1.78M$ -1.35M$ 435.00K$ -782.00K
Net Income
$ -1.03M$ -1.78K$ -1.35M$ 435.00K$ -782.00K
Per Share Metrics
Basic EPS
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Diluted EPS
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Weighted Average Shares Outstanding
673.04M 544.95M 544.91M 615.55M 514.21M
Weighted Average Shares Outstanding (Diluted)
704.16M 544.91M 544.91M 615.55M 514.21M
Currency in USD

Xtl Bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis